That may say something about Boehringer’s lack of clout in the US market. Perhaps they could benefit from a having a big name as a US marketing partner.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.